Product
ABP-450 (PrabotulinumtoxinA)
PHARMACEUTICAL
byAEON Biopharma, Inc.
United States (US)
ABOUT THE PRODUCT
A proprietary botulinum toxin developed by AEON Biopharma for the treatment of various nervous system-related conditions. It is designed as a biosimilar to BOTOX® with the goal of increasing access to effective therapies.
Information is owner-confirmed
Last updated Yesterday
Price range